1) solvent diffusion and evaporation method
溶剂扩散-挥发法
1.
METHODS Hollow microspheres containing ranitidine hydrochloride were prepared by a solvent diffusion and evaporation method using ethyl cellulose(EC) as carrier material and ethanol/ether as organic solvents.
方法:以乙基纤维素(EC)为载体材料,乙醇/乙醚为混合溶剂,采用溶剂扩散-挥发法制备盐酸雷尼替丁中空微球。
2) solvent evaporation method
溶剂挥发法
1.
The progress of preparing protein microspheres by solvent evaporation method;
溶剂挥发法制备蛋白质类微球的研究进展
2.
Dexamethasone sodium phosphate(DSP) Poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid)(PLEA)/SiO2 Microspheres(DSP-PLEA/SiO2 MS) were prepared in solvent evaporation method.
采用自制的聚乳酸-聚乙二醇-聚乳酸/SiO2(PELA/SiO2)材料作为药物载体,通过溶剂挥发法制备了地塞米松磷酸钠(DSP)微球,并对微球的粒径、载药量以及体外缓释性能进行了研究。
3.
Methods Co-poly lactic acid glycolic acid(PLGA) microsphere was prepared by a modified solvent evaporation method by a double emulsion with the use of polyvinylalcohol(PVA) as emulsification;PLGA was used as biodegradable m.
方法选择聚乙烯醇(PVA)作为助乳剂,聚乳酸聚羟基乙酸(PLGA)作为微球的生物可降解载体,二氯甲烷作为有机溶剂,溶剂蒸发温度为室温,运用溶剂挥发法制备W/O/W的双乳微球制剂。
3) Solvent evaporation
溶剂挥发法
1.
The powdered composite materials of β-TCP coated with polylactic acid are prepared by using different materials as the surface stabilizers in the preparation of microsphere via O/W emulsion solvent evaporation.
采用O/W乳液溶剂挥发法,以不同的物质作为微球制备过程中的表面稳定剂,制备了聚乳酸包覆磷酸钙粉末状复合材料。
2.
The PLGA microspheres loading nisoldipine were prepared by the solvent evaporation method.
采用溶剂挥发法制备了尼索地平微球 ,考察了制备工艺中影响微球质量的 5个主要因素 ,筛选出较理想的处方和工艺。
3.
Methods: Microspheres were prepared with(water-in-oil)-in-water emulsion solvent evaporation technique.
方法:采用复乳溶剂挥发法制备鼠疫疫苗微球,以激光粒度测定仪测定微球的平均粒径,以BCA法及微量BCA法测定微球的疫苗含量及疫苗从微球的释放,以ELISA法考察从微球中释放出的鼠疫疫苗的活性。
4) solvent diffusion method
溶剂扩散法
1.
Solid lipid nanoparticles (SLN) loaded with digoxin were prepared by solvent diffusion method using glyceryl monostearate as matrix material.
以单硬脂酸甘油酯为脂质材料,采用溶剂扩散法所制的地高辛固体脂质纳米粒于4℃贮存3个月,平均粒径增大,但包封率和载药量无显著变化。
2.
The solvent diffusion method was used to prepare PA nanoparticles.
采用溶剂扩散法制备乙酰化普鲁兰纳米粒,并通过透射电镜及动态光散射仪表征了纳米粒的形态和粒径,以考察各种因素对纳米粒形成的影响。
5) Solvent evaporation-phase separation
溶剂挥发成膜法
6) double emulsion-solvent evaporation technique
复乳-溶剂挥发法
1.
Methods The TP5-PLGA nanoparticles were prepared by using a double emulsion-solvent evaporation technique.
方法用复乳-溶剂挥发法制备TP5-PLGA纳米粒,以包封率为评价指标,用L16(45)正交设计优选纳米粒制备的处方工艺条件,用HPLC法测定胸腺五肽的含量,用激光粒度仪测定纳米粒的粒径,用透射电镜观察纳米粒的形态,用动态透析法考察纳米粒的体外释药特征。
补充资料：卤化物挥发法
分子式：
CAS号：
性质：干法后处理方法之一，利用含卤素试剂与乏燃料和元件包壳材料以及其他元素进行反应生成相应的卤化物，并利用其挥发性或化学性质上的差异来进行铀、钚(钍)或裂片元素的相互分离，以回收并纯化可裂变物质。
CAS号：
性质：干法后处理方法之一，利用含卤素试剂与乏燃料和元件包壳材料以及其他元素进行反应生成相应的卤化物，并利用其挥发性或化学性质上的差异来进行铀、钚(钍)或裂片元素的相互分离，以回收并纯化可裂变物质。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条